<DOC>
	<DOCNO>NCT01642901</DOCNO>
	<brief_summary>Maintenance bone mass follow spinal cord injury ( SCI ) essential fracture prevention associate morbidity bed rest secondary complication . Intravenous ( IV ) zoledronic acid ( ZA ) FDA-approved drug show effective agent reduce bone mass resorption leg fracture post-menopausal woman , study patient acute SCI . This randomized , double-blind , placebo-controlled trial IV ZA prevent bone loss early SCI . Up 48 subject randomize receive one-time dose 5 mg IV ZA versus placebo within 21 day SCI .</brief_summary>
	<brief_title>Zoledronic Acid Acute Spinal Cord Injury</brief_title>
	<detailed_description>Maintenance bone mass follow spinal cord injury ( SCI ) essential fracture prevention associate morbidity bed rest secondary complication . Intravenous ( IV ) zoledronic acid ( ZA ) show effective agent reduce bone mass resorption fracture legs post-menopausal woman , study acute spinal cord injury . Two previous study ZA person subacute SCI , promising , inconclusive . As state long range plan National Institute Disability Rehabilitation Research ( NIDRR ) , one goal area health function `` focus onset new conditionsâ€¦exacerbation exist condition , development coexist condition . '' This study intend demonstrate reduction loss bone mass hip knee region acute SCI rigorous study sufficient size determine effectiveness intervention .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Ages 1865 , male female Traumatic SCI Neurological level C4T10 , AIS ( ASIA Impairment Scale ) A , Serum calcium level &gt; 7.0 mg/dL ) time study drug administration Screening baseline serum 25OH ( 25hydroxy ) vitamin D least 13 ng/ml No medical contraindication supplemental vitamin D participant whose level &gt; 13 ng/ml subtherapeutic ( &lt; 32ng/ml ) No medical contraindication supplemental calcium Weight 300 pound , maximum permit DXA scanner Ventilatordependent individual Chronic steroid use ( define &gt; 6 month ) Rheumatoid disease use prior disease modify antirheumatic drug ( DMARDs ) affect bone density History osteoporosis treatment osteopenia osteoporosis bisphosphonates , selective reuptake estrogen modify agent Current use medications* include bisphosphonates treat osteoporosis ( *note prior calcium vitamin D use exclusion criterion ) History one low extremity osteoporosisrelated fracture Chronic renal insufficiency , creatinine clearance &lt; 35 ml/min , screen End stage liver kidney disease Medical condition result hypogonadal state affect bone density Uncontrolled thyroid disease/thyrotoxicosis Hereditary acquire metabolic bone disorder History use unfractionated heparin &gt; 1 year History select antiseizure medication , specifically phenobarbital , phenytoin , carbamazepine , sodium valproate &gt; 1 year Acute chronic bilateral lower extremity fracture involve tibia femur , placement surgical hardware area location Severe hypotension require use intravenous blood pressure agent dopamine , norepinephrine phenylephrine . Exception may allow patient pressor arm experience hypotension acclimate upright posture . Inability provide inform consent understand consent process Facial fracture require oral surgery Dental surgery oral maxillofacial surgery within 2 week anticipate study drug administration Pregnancy present admission Vitamin D deficiency admission test ( serum 25OH D report &lt; 13 ng/mL ) Patients establish reaction , history , anaphylactic shock aspirin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>spinal cord injury</keyword>
	<keyword>bone mineral density</keyword>
</DOC>